Have a feature idea you'd love to see implemented?
Let us know!
PRCT Procept BioRobotics Corp
Price (delayed)
$94.45
Market cap
$4.93B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.95
Enterprise value
$4.81B
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic
Highlights
PRCT's gross profit has surged by 90% year-on-year and by 19% since the previous quarter
Procept BioRobotics's revenue has surged by 72% YoY and by 13% QoQ
The quick ratio has declined by 37% year-on-year and by 22% since the previous quarter
The equity has declined by 19% year-on-year and by 4.2% since the previous quarter
Key stats
What are the main financial stats of PRCT
Market
Valuations
Earnings
Shares outstanding
52.18M
Market cap
$4.93B
Enterprise value
$4.81B
Price to earnings (P/E)
N/A
Price to book (P/B)
20.33
Price to sales (P/S)
24.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
24.08
Revenue
$199.84M
EBIT
-$95.72M
EBITDA
-$91.02M
Free cash flow
-$103.57M
Per share
Balance sheet
Liquidity
EPS
-$1.95
Free cash flow per share
-$1.99
Book value per share
$4.64
Revenue per share
$3.84
TBVPS
$7.17
Total assets
$374.14M
Total liabilities
$132.92M
Debt
$80.64M
Equity
$241.22M
Working capital
$269.34M
Debt to equity
0.33
Current ratio
6.02
Quick ratio
4.95
Net debt/EBITDA
1.28
Margins
Efficiency
Dividend
EBITDA margin
-45.5%
Gross margin
57.4%
Net margin
-50.1%
Operating margin
-53.3%
Return on assets
-26.1%
Return on equity
-38.6%
Return on invested capital
-49.1%
Return on capital employed
-29.9%
Return on sales
-47.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRCT stock price
How has the Procept BioRobotics stock price performed over time
Intraday
1.89%
1 week
9.94%
1 month
38.49%
1 year
180.1%
YTD
125.36%
QTD
17.89%
Financial performance
How have Procept BioRobotics's revenue and profit performed over time
Revenue
$199.84M
Gross profit
$114.68M
Operating income
-$106.46M
Net income
-$100.06M
Gross margin
57.4%
Net margin
-50.1%
PRCT's gross profit has surged by 90% year-on-year and by 19% since the previous quarter
Procept BioRobotics's revenue has surged by 72% YoY and by 13% QoQ
The net margin is up by 45% year-on-year and by 15% since the previous quarter
The company's operating margin rose by 41% YoY and by 14% QoQ
Growth
What is Procept BioRobotics's growth rate over time
Valuation
What is Procept BioRobotics stock price valuation
P/E
N/A
P/B
20.33
P/S
24.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
24.08
Procept BioRobotics's EPS has increased by 16% YoY and by 5% QoQ
PRCT's P/B is 74% above its last 4 quarters average of 11.7
The equity has declined by 19% year-on-year and by 4.2% since the previous quarter
Procept BioRobotics's revenue has surged by 72% YoY and by 13% QoQ
The stock's price to sales (P/S) is 42% more than its last 4 quarters average of 17.3
Efficiency
How efficient is Procept BioRobotics business performance
Procept BioRobotics's return on sales has increased by 46% YoY and by 15% QoQ
PRCT's ROIC is up by 28% YoY and by 8% QoQ
The ROE has grown by 25% YoY
Procept BioRobotics's ROA has increased by 21% YoY
Dividends
What is PRCT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PRCT.
Financial health
How did Procept BioRobotics financials performed over time
Procept BioRobotics's total assets is 181% more than its total liabilities
The quick ratio has declined by 37% year-on-year and by 22% since the previous quarter
Procept BioRobotics's current ratio has decreased by 32% YoY and by 20% from the previous quarter
The debt is 67% smaller than the equity
The debt to equity has increased by 22% year-on-year and by 3.1% since the previous quarter
The equity has declined by 19% year-on-year and by 4.2% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.